Chromoendoscopy in diagnosis of gastric intestinal metaplasia: a muticenter prospecive randomized control trial

Chromoendoscopy in diagnosis of gastric intestinal metaplasia: a muticenter prospecive randomized control trial - IM-chromo study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003045

Enrollment

200

Registered

2010-02-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric intestinal metaplasia

Interventions

Chromoendoscopy with indigo carmine Conventional endoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients require esophago-gastro-duodenoscopy and gave written informed consent

Exclusion criteria

Exclusion criteria: Patients who are suspicious of advanced malignancy, having symptoms of acute gastrointestinal hemorrhage, history of H. pylori eradication, diagnosed as having intestinal metaplasia, gastrectomy, NSAIDS, anticoaglants and antiplatelet aggregation agents with in one week, severe organ failure, pregnancy

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy for intestinal metaplasia	—

Countries

Japan

Contacts

Public ContactNoriya Uedo

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Gastrointestinal Oncology

uedou-no@mc.pref.osaka.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026